Inovio Pharmaceuticals Inc. (INO) released a profit for fourth quarter that decreased from last year
The company's bottom line came in at $19.4 million, or $0.65 per share. This compares with $25.0 million, or $1.10 per share, last year.
The company's revenue for the period fell 46.3% to $0.117 million from $0.218 million last year.
Inovio Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings: $19.4 Mln. vs. $25.0 Mln. last year.
-EPS: $0.65 vs. $1.10 last year.
-Revenue: $0.117 Mln vs. $0.218 Mln last year.
For comments and feedback: editorial@rttnews.com